Contact lens giant Bausch & Lomb creates 125 extra Waterford jobs
Bausch & Lomb opens €85m extension to bring total Waterford employment to 1,300
Perrigo to review options for multiple sclerosis drug Tysabri
CEO John Hendrickson says drug faces increased competition and potential for wider use has failed to materialise
Perrigo shares slide as drugmaker slashes full-year forecast again
Company sales have halved since the company rejected Mylan takeover offer late last year
Valeant names Papa as its new CEO
Joseph Papa confirms position day after he resigns from the top spot at drugmaker Perrigo
Mylan admits that bid for Dublin-based Perrigo has failed
Drugmaker said it fell short of 50% share threshold in tender offer
Perrigo’s CEO confident shareholders will reject Mylan deal
Joseph Papa said shareholders are unlikely to accept a hostile $27.1 bn takeover bid from Mylan
Mylan shareholders to vote on Perrigo acquisition
Mylan seeks to acquire Perrigo in a $36bn deal opposed by Perrigo’s board of directors
Mylan and Perrigo each win backing in hostile takeover battle
Proxy advisor ISS says bid for Dublin-based Perrigo too expensive, but Mylan investor and hedge fund Paulson
Perrigo rejects $29bn bid from generics group Mylan
Irish company says unsolicited bid undervalues company and does not reflect growth potential
Generics group Mylan swoops on rival Perrigo with $28.9bn deal
Surprise bid signals reluctance of Perrigo to agree friendly merger in behind the scenes dialogue and continues record period of pharma sector consolidation
Elan sale vindicates rebuffing of Royalty
Perrigo deal will end uncertainty for Irish drugmaker after equity firm’s bids
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices